The race to make vaccines for a dangerous respiratory virus

Kendall Powell

Nature, 2021, vol. 600, issue 7889, 379-380

Abstract: Millions of people a year are hospitalized by respiratory syncytial virus and tens of thousands die. After decades of failure, four vaccines are now in late-stage trials.

Keywords: Virology; Vaccines; Industry (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-021-03704-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:600:y:2021:i:7889:d:10.1038_d41586-021-03704-y

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-021-03704-y

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().